WASHINGTON—U.S. national-security officials are reviewing the 2017 acquisition of a South Carolina pharmaceutical company by Chinese investors after learning the firm was in talks to participate in a Pentagon project to develop injection devices for a coronavirus vaccine, according to people familiar with the matter.
The Committee on Foreign Investment in the U.S.’s inquiry into the acquisition of Ritedose Corp. of Columbia, S.C., was also referenced in a statement by the Pentagon’s Defense Logistics Agency, which earlier…
